• Home
  • Commercial & Medical
  • Sandoz reorg ahead of ‘golden decade’ for biosimilars; Sanofi to shed Latin America generics business

Sandoz said it will separate its biosimilar unit from generics, since both businesses have different manufacturing and commercial needs. The move is ahead of what it calls a “golden decade” for …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844